EE261 Cost-Effectiveness of Adding Darolutamide to Docetaxel and Androgen Deprivation Therapy in the Treatment of Metastatic Hormone-Sensitive Prostrate Cancer
Jun 1, 2023, 00:00 AM
10.1016/j.jval.2023.03.562
https://www.valueinhealthjournal.com/article/S1098-3015(23)00662-9/fulltext
Section Title :
Section Order :
10044
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)00662-9&doi=10.1016/j.jval.2023.03.562